pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Delivering for patients and sites in 2025 | pharmaphorum
Dec 18, 2024 · Neumora laid low by depression trial failure. The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price.
News | Timely industry updates for pharma and biotech leaders
3 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
About pharmaphorum
4 days ago · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Pharma | pharmaphorum
Unlocking impact and growth at times of demerger. Pharma and medtech companies have undergone unprecedented growth through aggressive M&A over the
Heard on the pipeline: Access to medication - pharmaphorum
Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years. Yet, while discussions have been plentiful, even fruitful, patients around the world still struggle to access treatments.
Novo Nordisk asks FDA not to allow GLP-1 compounding
23 hours ago · Novo joins Lilly in asking FDA for ban on GLP-1 compounding. Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity ...
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those questioned, during a period which has seen the first gene therapies marketed, as …
The AI revolution in pharma | pharmaphorum
Dec 31, 2024 · The AI revolution in pharma and biotech is transforming the healthcare industry. Discover how artificial intelligence is revolutionising drug discovery, precision medicine, and patient care.